These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 2555788

  • 1. Aphidicolin resistance in herpes simplex virus type I reveals features of the DNA polymerase dNTP binding site.
    Hall JD, Wang YS, Pierpont J, Berlin MS, Rundlett SE, Woodward S.
    Nucleic Acids Res; 1989 Nov 25; 17(22):9231-44. PubMed ID: 2555788
    [Abstract] [Full Text] [Related]

  • 2. Aphidicolin resistance in herpes simplex virus type 1 appears to alter substrate specificity in the DNA polymerase.
    Hall JD, Woodward S.
    J Virol; 1989 Jun 25; 63(6):2874-6. PubMed ID: 2542598
    [Abstract] [Full Text] [Related]

  • 3. Single mutations at many sites within the DNA polymerase locus of herpes simplex viruses can confer hypersensitivity to aphidicolin and resistance to phosphonoacetic acid.
    Honess RW, Purifoy DJ, Young D, Gopal R, Cammack N, O'Hare P.
    J Gen Virol; 1984 Jan 25; 65 ( Pt 1)():1-17. PubMed ID: 6319564
    [Abstract] [Full Text] [Related]

  • 4. A single-base change within the DNA polymerase locus of herpes simplex virus type 2 can confer resistance to aphidicolin.
    Tsurumi T, Maeno K, Nishiyama Y.
    J Virol; 1987 Feb 25; 61(2):388-94. PubMed ID: 3027369
    [Abstract] [Full Text] [Related]

  • 5. Mutations in the herpes simplex virus DNA polymerase gene conferring hypersensitivity to aphidicolin.
    Coen DM, Furman PA, Aschman DP, Schaffer PA.
    Nucleic Acids Res; 1983 Aug 11; 11(15):5287-97. PubMed ID: 6308578
    [Abstract] [Full Text] [Related]

  • 6. In vitro mutagenesis of the herpes simplex virus type 1 DNA polymerase gene results in altered drug sensitivity of the enzyme.
    Matthews JT, Carroll RD, Stevens JT, Haffey ML.
    J Virol; 1989 Nov 11; 63(11):4913-8. PubMed ID: 2552170
    [Abstract] [Full Text] [Related]

  • 7. Use of suppressor analysis to identify DNA polymerase mutations in herpes simplex virus which affect deoxynucleoside triphosphate substrate specificity.
    Wang YS, Woodward S, Hall JD.
    J Virol; 1992 Mar 11; 66(3):1814-6. PubMed ID: 1310785
    [Abstract] [Full Text] [Related]

  • 8. Characterization of an aphidicolin-resistant mutant of herpes simplex virus type 2 which induces an altered viral DNA polymerase.
    Nishiyama Y, Suzuki S, Yamauchi M, Maeno K, Yoshida S.
    Virology; 1984 May 11; 135(1):87-96. PubMed ID: 6328755
    [Abstract] [Full Text] [Related]

  • 9. Genetic characterization of the vaccinia virus DNA polymerase: identification of point mutations conferring altered drug sensitivities and reduced fidelity.
    Taddie JA, Traktman P.
    J Virol; 1991 Feb 11; 65(2):869-79. PubMed ID: 1898973
    [Abstract] [Full Text] [Related]

  • 10. Mutations in the herpes simplex virus major DNA-binding protein gene leading to altered sensitivity to DNA polymerase inhibitors.
    Chiou HC, Weller SK, Coen DM.
    Virology; 1985 Sep 11; 145(2):213-26. PubMed ID: 2992151
    [Abstract] [Full Text] [Related]

  • 11. A point mutation within a distinct conserved region of the herpes simplex virus DNA polymerase gene confers drug resistance.
    Hwang CB, Ruffner KL, Coen DM.
    J Virol; 1992 Mar 11; 66(3):1774-6. PubMed ID: 1310779
    [Abstract] [Full Text] [Related]

  • 12. Engineered herpes simplex virus DNA polymerase point mutants: the most highly conserved region shared among alpha-like DNA polymerases is involved in substrate recognition.
    Marcy AI, Hwang CB, Ruffner KL, Coen DM.
    J Virol; 1990 Dec 11; 64(12):5883-90. PubMed ID: 2173770
    [Abstract] [Full Text] [Related]

  • 13. Mutations in the Exo III motif of the herpes simplex virus DNA polymerase gene can confer altered drug sensitivities.
    Hwang YT, Smith JF, Gao L, Hwang CB.
    Virology; 1998 Jul 05; 246(2):298-305. PubMed ID: 9657948
    [Abstract] [Full Text] [Related]

  • 14. Physical mapping of drug resistance mutations defines an active center of the herpes simplex virus DNA polymerase enzyme.
    Knopf KW, Kaufman ER, Crumpacker C.
    J Virol; 1981 Sep 05; 39(3):746-57. PubMed ID: 6270349
    [Abstract] [Full Text] [Related]

  • 15. Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus.
    Coen DM, Fleming HE, Leslie LK, Retondo MJ.
    J Virol; 1985 Feb 05; 53(2):477-88. PubMed ID: 2982032
    [Abstract] [Full Text] [Related]

  • 16. The herpes simplex virus type 1 DNA polymerase gene: site of phosphonoacetic acid resistance mutation in strain Angelotti is highly conserved.
    Knopf CW.
    J Gen Virol; 1987 May 05; 68 ( Pt 5)():1429-33. PubMed ID: 3033142
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sequence and mapping analyses of the herpes simplex virus DNA polymerase gene predict a C-terminal substrate binding domain.
    Gibbs JS, Chiou HC, Hall JD, Mount DW, Retondo MJ, Weller SK, Coen DM.
    Proc Natl Acad Sci U S A; 1985 Dec 05; 82(23):7969-73. PubMed ID: 2999787
    [Abstract] [Full Text] [Related]

  • 19. Susceptibility of phosphonoformic acid-resistant herpes simplex virus variants to arabinosylnucleosides and aphidicolin.
    Bastow KF, Derse DD, Cheng YC.
    Antimicrob Agents Chemother; 1983 Jun 05; 23(6):914-7. PubMed ID: 6311091
    [Abstract] [Full Text] [Related]

  • 20. Mutations in the herpes simplex virus DNA polymerase gene can confer resistance to 9-beta-D-arabinofuranosyladenine.
    Coen DM, Furman PA, Gelep PT, Schaffer PA.
    J Virol; 1982 Mar 05; 41(3):909-18. PubMed ID: 6284981
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.